Inhibrx Biosciences二次修订协议带来总计3.25亿美元资金,含1亿美元已到位与2.25亿美元可用额度

美股速递
Jul 16

Inhibrx Biosciences公司通过其第二次修订协议,成功锁定了高达3.25亿美元的资金支持。该资金安排结构清晰,其中1亿美元已确认获得融资,另有2.25亿美元作为可用额度待后续启用。这一举措显著增强了公司的财务灵活性与研发推进能力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10